Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors

被引:49
作者
Guo, Dong [1 ,2 ]
Heitman, Laura H. [1 ]
IJzerman, Adriaan P. [1 ]
机构
[1] Leiden Univ, LACDR, Div Med Chem, POB 9502, NL-2300 RA Leiden, Netherlands
[2] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China
关键词
HIGH-AFFINITY ANTAGONIST; TARGET RESIDENCE TIME; AGONIST ALLOSTERIC ENHANCERS; FLUORESCENCE CORRELATION SPECTROSCOPY; SUPERVISED MOLECULAR-DYNAMICS; SITE-DIRECTED MUTAGENESIS; XANTHINE AMINE CONGENER; BIOLOGICAL EVALUATION; A(2A) RECEPTOR; BINDING-KINETICS;
D O I
10.1021/acs.chemrev.6b00025
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Ligand-receptor binding kinetics is an emerging topic in the drug research community. Over the past years, medicinal chemistry approaches from a kinetic perspective have been increasingly applied to G protein-coupled receptors including the adenosine receptors (AR), which are involved in a plethora of physiological and pathological conditions. The study of ligand-AR binding kinetics offers room for detailed structure kinetics relationships next to more traditional structure activity relationships. Their combination may facilitate the triage of candidate compounds in hit-to-lead campaigns. Furthermore, kinetic studies also help in understanding AR allosterism. Allosteric modulation may yield a change in the activity and conformation of a receptor resulting from the binding of a compound at a site distinct from where the endogenous agonist adenosine binds. Hence, in this Review, we summarize available data and evidence for the binding kinetics of orthosteric and allosteric AR ligands. We hope this Review will raise awareness to consider the kinetic aspects of drug target interactions on both ARs and other drug targets.
引用
收藏
页码:38 / 66
页数:29
相关论文
共 238 条
[1]   APPLICATION OF THE THEORY OF DIFFUSION-CONTROLLED REACTIONS TO ENZYME KINETICS [J].
ALBERTY, RA ;
HAMMES, GG .
JOURNAL OF PHYSICAL CHEMISTRY, 1958, 62 (02) :154-159
[2]   [3H]ZM241385 -: an antagonist radioligand for adenosine A2A receptors in rat brain [J].
Alexander, SPH ;
Millns, PJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 411 (03) :205-210
[3]  
[Anonymous], 1997, NAUNYN SCHMIEDEBERGS, DOI DOI 10.1007/PL00005131
[4]   Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity [J].
Antony, Johannes ;
Kellershohn, Kerstin ;
Mohr-Andrae, Marion ;
Kebig, Anna ;
Prilla, Stefanie ;
Muth, Mathias ;
Heller, Eberhard ;
Disingrini, Teresa ;
Dallanoce, Clelia ;
Bertoni, Simona ;
Schrobang, Jasmin ;
Traenkle, Christian ;
Kostenis, Evi ;
Christopoulos, Arthur ;
Hoeltje, Hans-Dieter ;
Barocelli, Elisabetta ;
De Amici, Marco ;
Holzgrabe, Ulrike ;
Mohr, Klaus .
FASEB JOURNAL, 2009, 23 (02) :442-450
[5]   Phase II failures: 2008-2010 [J].
Arrowsmith, John .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) :1-1
[6]   Synthesis and pharmacological characterization of [125I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor [J].
Auchampach, John A. ;
Gizewski, Elizabeth T. ;
Wan, Tina C. ;
de Castro, Sonia ;
Brown, Garth G., Jr. ;
Jacobson, Kenneth A. .
BIOCHEMICAL PHARMACOLOGY, 2010, 79 (07) :967-973
[7]   5-substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers [J].
Aurelio, Luigi ;
Figler, Heidi ;
Flynn, Bernard L. ;
Linden, Joel ;
Scammells, Peter J. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (03) :1319-1327
[8]   A dynamic view of cellular processes by in vivo fluorescence auto- and cross-correlation spectroscopy [J].
Bacia, K ;
Schwille, P .
METHODS, 2003, 29 (01) :74-85
[9]  
Ballesteros JA, 1995, INTEGRATED METHODS C, P366
[10]   Synthesis and biological characterization of [3H] (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)-methanone, the first radiolabelled adenosine A1 allosteric enhancer [J].
Baraldi, PG ;
Pavani, MG ;
Leung, E ;
Moorman, AR ;
Varani, K ;
Vincenzi, F ;
Borea, PA ;
Romagnoli, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) :1402-1404